NEXTEDIA (ALNXT.PA) Stock Fundamental Analysis

EPA:ALNXT • FR0004171346

0.39 EUR
+0 (+1.04%)
Last: Feb 25, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

ALNXT gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 65 industry peers in the IT Services industry. While ALNXT seems to be doing ok healthwise, there are quite some concerns on its profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on ALNXT.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • ALNXT had positive earnings in the past year.
  • In the past year ALNXT had a positive cash flow from operations.
  • In the past 5 years ALNXT has always been profitable.
  • ALNXT had a positive operating cash flow in 4 of the past 5 years.
ALNXT.PA Yearly Net Income VS EBIT VS OCF VS FCFALNXT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

  • With a Return On Assets value of 2.83%, ALNXT is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
  • Looking at the Return On Equity, with a value of 4.93%, ALNXT is doing worse than 63.08% of the companies in the same industry.
  • The Return On Invested Capital of ALNXT (6.30%) is worse than 60.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ALNXT is significantly below the industry average of 11.74%.
  • The last Return On Invested Capital (6.30%) for ALNXT is above the 3 year average (6.20%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.83%
ROE 4.93%
ROIC 6.3%
ROA(3y)2.64%
ROA(5y)3.08%
ROE(3y)5.31%
ROE(5y)6.42%
ROIC(3y)6.2%
ROIC(5y)6.1%
ALNXT.PA Yearly ROA, ROE, ROICALNXT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

  • ALNXT has a Profit Margin of 2.50%. This is comparable to the rest of the industry: ALNXT outperforms 41.54% of its industry peers.
  • ALNXT's Profit Margin has declined in the last couple of years.
  • ALNXT's Operating Margin of 5.15% is in line compared to the rest of the industry. ALNXT outperforms 46.15% of its industry peers.
  • ALNXT's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 54.19%, ALNXT is doing worse than 61.54% of the companies in the same industry.
  • ALNXT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.15%
PM (TTM) 2.5%
GM 54.19%
OM growth 3Y-10.16%
OM growth 5Y-2.26%
PM growth 3Y-8.02%
PM growth 5Y-2.63%
GM growth 3Y-8.46%
GM growth 5Y-11.02%
ALNXT.PA Yearly Profit, Operating, Gross MarginsALNXT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALNXT is destroying value.
  • ALNXT has about the same amout of shares outstanding than it did 1 year ago.
  • ALNXT has more shares outstanding than it did 5 years ago.
  • ALNXT has a better debt/assets ratio than last year.
ALNXT.PA Yearly Shares OutstandingALNXT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ALNXT.PA Yearly Total Debt VS Total AssetsALNXT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • ALNXT has an Altman-Z score of 2.11. This is not the best score and indicates that ALNXT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ALNXT's Altman-Z score of 2.11 is in line compared to the rest of the industry. ALNXT outperforms 43.08% of its industry peers.
  • ALNXT has a debt to FCF ratio of 3.10. This is a good value and a sign of high solvency as ALNXT would need 3.10 years to pay back of all of its debts.
  • ALNXT's Debt to FCF ratio of 3.10 is in line compared to the rest of the industry. ALNXT outperforms 56.92% of its industry peers.
  • ALNXT has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.12, ALNXT is doing good in the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 3.1
Altman-Z 2.11
ROIC/WACC0.95
WACC6.63%
ALNXT.PA Yearly LT Debt VS Equity VS FCFALNXT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • ALNXT has a Current Ratio of 1.25. This is a normal value and indicates that ALNXT is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.25, ALNXT perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
  • ALNXT has a Quick Ratio of 1.25. This is a normal value and indicates that ALNXT is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Quick ratio value of 1.25, ALNXT is doing good in the industry, outperforming 61.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 1.25
ALNXT.PA Yearly Current Assets VS Current LiabilitesALNXT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 48.13% over the past year.
  • ALNXT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.66% yearly.
  • ALNXT shows a decrease in Revenue. In the last year, the revenue decreased by -2.25%.
  • ALNXT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.48% yearly.
EPS 1Y (TTM)48.13%
EPS 3Y-3.66%
EPS 5Y3.66%
EPS Q2Q%4.76%
Revenue 1Y (TTM)-2.25%
Revenue growth 3Y8.74%
Revenue growth 5Y21.48%
Sales Q2Q%-8.17%

3.2 Future

  • ALNXT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.47% yearly.
  • Based on estimates for the next years, ALNXT will show a quite strong growth in Revenue. The Revenue will grow by 8.18% on average per year.
EPS Next Y20.64%
EPS Next 2Y9.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.87%
Revenue Next 2Y8.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALNXT.PA Yearly Revenue VS EstimatesALNXT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALNXT.PA Yearly EPS VS EstimatesALNXT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2022 2023 2024 2025 2026 0.02 0.04 0.06 0.08

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 9.75, the valuation of ALNXT can be described as reasonable.
  • Compared to the rest of the industry, the Price/Earnings ratio of ALNXT indicates a rather cheap valuation: ALNXT is cheaper than 89.23% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.05. ALNXT is valued rather cheaply when compared to this.
  • ALNXT is valuated cheaply with a Price/Forward Earnings ratio of 4.21.
  • Based on the Price/Forward Earnings ratio, ALNXT is valued cheaper than 95.38% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.03, ALNXT is valued rather cheaply.
Industry RankSector Rank
PE 9.75
Fwd PE 4.21
ALNXT.PA Price Earnings VS Forward Price EarningsALNXT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, ALNXT is valued a bit cheaper than the industry average as 70.77% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.33
EV/EBITDA N/A
ALNXT.PA Per share dataALNXT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.47
PEG (5Y)2.66
EPS Next 2Y9.47%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ALNXT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NEXTEDIA

EPA:ALNXT (2/25/2026, 7:00:00 PM)

0.39

+0 (+1.04%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners17.68%
Ins Owner ChangeN/A
Market Cap15.21M
Revenue(TTM)62.04M
Net Income(TTM)1.55M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.75
Fwd PE 4.21
P/S 0.25
P/FCF 8.33
P/OCF 7.96
P/B 0.48
P/tB 13.12
EV/EBITDA N/A
EPS(TTM)0.04
EY10.26%
EPS(NY)0.09
Fwd EY23.77%
FCF(TTM)0.05
FCFY12%
OCF(TTM)0.05
OCFY12.56%
SpS1.59
BVpS0.81
TBVpS0.03
PEG (NY)0.47
PEG (5Y)2.66
Graham Number0.85
Profitability
Industry RankSector Rank
ROA 2.83%
ROE 4.93%
ROCE 8.85%
ROIC 6.3%
ROICexc 7.81%
ROICexgc N/A
OM 5.15%
PM (TTM) 2.5%
GM 54.19%
FCFM 2.94%
ROA(3y)2.64%
ROA(5y)3.08%
ROE(3y)5.31%
ROE(5y)6.42%
ROIC(3y)6.2%
ROIC(5y)6.1%
ROICexc(3y)8.02%
ROICexc(5y)8.4%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.71%
ROCE(5y)8.58%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-9.69%
ROICexc growth 5Y-0.48%
OM growth 3Y-10.16%
OM growth 5Y-2.26%
PM growth 3Y-8.02%
PM growth 5Y-2.63%
GM growth 3Y-8.46%
GM growth 5Y-11.02%
F-Score7
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 3.1
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.14%
Interest Coverage 250
Cash Conversion N/A
Profit Quality 117.82%
Current Ratio 1.25
Quick Ratio 1.25
Altman-Z 2.11
F-Score7
WACC6.63%
ROIC/WACC0.95
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.47%
Cap/Sales(5y)0.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.13%
EPS 3Y-3.66%
EPS 5Y3.66%
EPS Q2Q%4.76%
EPS Next Y20.64%
EPS Next 2Y9.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.25%
Revenue growth 3Y8.74%
Revenue growth 5Y21.48%
Sales Q2Q%-8.17%
Revenue Next Year13.87%
Revenue Next 2Y8.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.19%
EBIT growth 3Y-2.31%
EBIT growth 5Y18.73%
EBIT Next Year22.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.15%
FCF growth 3Y-11.08%
FCF growth 5YN/A
OCF growth 1Y-33.49%
OCF growth 3Y-10.82%
OCF growth 5YN/A

NEXTEDIA / ALNXT.PA FAQ

Can you provide the ChartMill fundamental rating for NEXTEDIA?

ChartMill assigns a fundamental rating of 5 / 10 to ALNXT.PA.


What is the valuation status of NEXTEDIA (ALNXT.PA) stock?

ChartMill assigns a valuation rating of 7 / 10 to NEXTEDIA (ALNXT.PA). This can be considered as Undervalued.


What is the profitability of ALNXT stock?

NEXTEDIA (ALNXT.PA) has a profitability rating of 3 / 10.


How financially healthy is NEXTEDIA?

The financial health rating of NEXTEDIA (ALNXT.PA) is 5 / 10.